☆ 4.7 Article

Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors

Yassir Boulaamane et al.

Summary: Coumarins connected to position 6 exhibit higher selectivity towards MAO-B, while those connected to position 7 are relatively unstable. Molecular docking and dynamics simulations can help in elucidating the molecular interactions responsible for this selectivity, providing insights for further drug development against Parkinson's disease.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

添加到收藏夹

Article Chemistry, Physical

Aldoxime- and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors

Jong Min Oh et al.

Summary: A panel of chalcone derivatives were evaluated for their inhibitory activities, and HC6 was found to be the most potent inhibitor of MAO-B. HC3 and ACE7 also showed high inhibitory activity. These findings suggest that HC3 and HC6 hold promise as potential candidates for neurological disorder treatments.

JOURNAL OF MOLECULAR STRUCTURE (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Exploration of the Detailed Structure-Activity Relationships ofIsatin and Their Isomers As Monoamine Oxidase Inhibitors

Sunil Kumar et al.

Summary: Monoamine oxidase (MAO) is a key protein involved in the metabolism of neuroamines and has emerged as a potential drug target for neurodegenerative diseases. Isatin, a reversible inhibitor for MAO enzymes, shows high selectivity for MAO-B. This comprehensive review discusses the structure-activity relationships of isatins and their analogues for the design and development of new MAO inhibitors for neurodegenerative diseases.

ACS OMEGA (2022)

添加到收藏夹

Article Nutrition & Dietetics

Potent Bioactive Compounds From Seaweed Waste to Combat Cancer Through Bioinformatics Investigation

Kaushik Kumar Bharadwaj et al.

Summary: The utilization of marine resources, specifically the bioactive compounds from edible seaweed waste, for cancer drug development was explored in this study. Through in silico methodologies, a potential HDAC 2 inhibitor was identified and its binding to the protein was validated. Further research, both in vitro and in vivo, is encouraged based on the findings.

FRONTIERS IN NUTRITION (2022)

添加到收藏夹

Article Chemistry, Physical

Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease

Mohamed A. Abdelgawad et al.

Summary: This study evaluated the inhibitory activities of a series of alpha,beta-unsaturated ketone compounds against MAO-A and MAO-B. CHB3 and CHF3 showed the most potent inhibitory activity against MAO-B and were identified as reversible competitive inhibitors. CHB3 was considered a potential candidate for treating neurological disorders such as Parkinson's disease.

JOURNAL OF MOLECULAR STRUCTURE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors

Marco Mellado et al.

Summary: The research demonstrated the potential of chalcones as selective inhibitors of MAO-B, with analysis of structure-activity relationship to enhance inhibitory efficacy and selectivity.

BIOORGANIC CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Halogenated Coumarin-Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors

Nisha Abdul Rehuman et al.

Summary: A series of halogenated coumarin-chalcones were synthesized and evaluated for their inhibitory activities against several enzymes. Compound CC2 showed potent inhibition of MAO-B with high selectivity, as well as competitive inhibition of BChE. These compounds have the potential to be drug candidates for neurodegenerative disorders.

ACS OMEGA (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review

Vishal Payyalot Koyiparambath et al.

Summary: In recent years, Monoamine oxidase (MAO) has become a target for treating neurodegenerative diseases such as anxiety, depression, Alzheimer's, and Parkinson's diseases. Coumarins, known for their ease of synthesis, high therapeutic potential, and reversibility in inhibiting MAOs, are considered potent scaffold among several classes of inhibitors. This review focuses on the research in this field from 2014 to 2020, with a major emphasis on the structure-activity relationship of coumarin derivatives.

CHEMICAL BIOLOGY & DRUG DESIGN (2021)

添加到收藏夹

Review Chemistry, Medicinal

Recent Updates on Pyrazoline Derivatives as Promising Candidates for Neuropsychiatric and Neurodegenerative Disorders

T. M. Rangarajan et al.

Summary: Pyrazolines are five-membered heterocyclic compounds with two nitrogen atoms, serving as a privileged scaffold for diverse bioactive compounds. Synthesized from chalcones and hydrazine derivatives, they can greatly enhance physicochemical and pharmacological properties, particularly for CNS-related issues such as neurodegenerative disorders.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B

Luca G. Iacovino et al.

Summary: A library of monosubstituted chalcones with electron-donating and electron-withdrawing groups on aromatic rings was selected for evaluation. Compounds 13 and 14 were found to inhibit MAO-B and may be worth considering as novel MAO-B-selective inhibitors for neurodegenerative disease treatment.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Review Biochemical Research Methods

Quantitative Structure-Activity Relationship (QSAR) Studies for the Inhibition of MAOs

Muthusamy Ramesh et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)

添加到收藏夹

Review Chemistry, Medicinal

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors

Paolo Guglielmi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Integrated Binary QSAR-Driven Virtual Screening and In Vitro Studies for Finding Novel hMAO-B-Selective Inhibitors

Yusuf Serhat Is et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

添加到收藏夹

Editorial Material Biochemical Research Methods

Inhibitors of Monoamine Oxidase and Acetylcholinesterase as a Front Runner in CNS Drug Discovery

Bijo Mathew et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Efficient solvent- and temperature-tuned access to aldoxime ethers and phenolic functions by Pd-catalyzed C-O cross-coupling of aldoximes with aryl bromides and bromo-chalcones

Reeta et al.

NEW JOURNAL OF CHEMISTRY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identifying natural compounds as multi-target-directed ligands against Alzheimer's disease: an in silico approach

Pravin Ambure et al.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Panomles Approach in Neurodegenerative Disorders

Balazs Szatmari et al.

CURRENT MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?

Paolo Guglielmi et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

添加到收藏夹

Review Chemistry, Medicinal

Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update

Rati Kailash Prasad Tripathi et al.

MEDICINAL RESEARCH REVIEWS (2019)

添加到收藏夹

Review Chemistry, Medicinal

MAO inhibitors and their wider applications: a patent review

Simone Carradori et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Use of monoamine oxidase inhibitors in chronic neurodegeneration

Peter Riederer et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)

添加到收藏夹

Article Chemistry, Physical

Pharmacophore-Based 3D-QSAR Analysis of Thienyl Chalcones as a New Class of Human MAO-B Inhibitors: Investigation of Combined Quantum Chemical and Molecular Dynamics Approach

Bijo Mathew et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2017)

添加到收藏夹

Review Biochemical Research Methods

Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review

Bijo Mathew et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2017)

添加到收藏夹

Article Clinical Neurology

Molecular aspects of monoamine oxidase B

Rona R. Ramsay

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)

添加到收藏夹

Article Chemistry, Multidisciplinary

QSARINS: A new software for the development, analysis, and validation of QSAR MLR models

Paola Gramatica et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors

Se-Young Son et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

添加到收藏夹

Article Chemistry, Medicinal

Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs

Claudia Binda et al.

JOURNAL OF MEDICINAL CHEMISTRY (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.